Concepedia

Anuj Verma

AV

11

Publications

329

Citations

11

H-Index

2011

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Homi Bhabha National Institute

Tata Memorial Hospital

Anuj Verma is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, oncology, and pathology.

ORCID

Top concepts

Publications per year

2011–2022

11

Publications

11

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Kanwal Raghav, Suyu Liu, Michael J. Overman et al. · Cancer Discovery · 2021 · 71 citations · Full text

Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC

Aliya Qayyum, Ken‐Pin Hwang, Jason Stafford et al. · Journal for ImmunoTherapy of Cancer · 2019 · 50 citations · Full text

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik et al. · Clinical Cancer Research · 2021 · 49 citations · Full text

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Benny Johnson, Cara Haymaker, Edwin R. Parra et al. · Journal for ImmunoTherapy of Cancer · 2022 · 48 citations · Full text

Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors

Daniel M. Halperin, Suyu Liu, Arvind Dasari et al. · JAMA Oncology · 2022 · 36 citations · Full text

Rows per page

1–5 of 11